Lexaria Bioscience Corp (CNSX:LXX)

Lexaria Bioscience Corp (CNSX:LXX)

Share Price
$ 0.99
-0.07 (-6.60 %)
Market Cap
$77.85 m
Proactive Investors - Run By Investors For Investors

Lexaria Bioscience Corp

Lexaria Bioscience Corp. (CSE:LXX; OTCBB:LXRP) has developed and out-licenses its disruptive and cost-effective DehydraTECH™ technology that promotes healthier administration methods, lower overall dosing and higher effectiveness of ingestible drugs and other beneficial molecules.

Many vitamins, drugs, supplements and other beneficial molecules are lipophilic (i.e. fat soluble) and...

Market: CSE:LXX
52-week High/Low: C$2.90 / C$0.98
Sector: Cannabis
Market Cap: $77.85 m
Website: www.lexariabioscience.com
col 3
col 4
col 5
col 6

Big Picture – A Deep Dive Examination of Lexaria Bioscience Corp

Lexaria Bioscience Corp Timeline

Copyright © Proactiveinvestors.com, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use